Evidence Hub

Long term follow up of 3 patients after resection of mediastinal paraganglioma necessitating cardiopulmonary bypass: case series

Forhad Ullah, Andre Rafizadeh, Y. Woo, F. Steiner, S. Xydas, Zoltán Németh

Journal of Surgical Case Reports, 2024

1 citation

Abstract

Abstract Paragangliomas are rare neuroendocrine tumors originating from extra-adrenal paraganglia that often require intricate surgical resection. Specifically, when paragangliomas are localized within the thorax and coexist with cardiovascular structures, they can be challenging to surgically resect. Here, we aimed to review three cases of paragangliomas intruding the aortopulmonary (AP) window that required cardiopulmonary bypass (CPB) as an effective surgical approach. All patients were diagnosed using preoperative biochemical analysis, computed tomography-positron emission tomography (CT-PET) scans, endobronchial ultrasounds, and biopsies. Within these three cases of female patients presenting with paragangliomas within the AP window, we observed a high success rate in complete surgical resection and no long-term recurrence following resections with CPB. Overall, these cases showed that surgical resection of paragangliomas which are intruding vital cardiovascular structures within the AP window can achieve positive long-term patient outcomes when using CPB.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free